yttrium has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeNardo, GL; DeNardo, SJ; Kukis, DL; Lamborn, KR; Meyers, FJ; Miers, LA; O'Donnell, RT | 1 |
| Chong, SY; Gao, H; Han, S; Ji, X; Jung, S; Liu, X; Luo, B; Mao, Y; Ren, H; Shen, C; Shi, P; Wang, JW; Yeo, XY; Yi, Z | 1 |
2 other study(ies) available for yttrium and paclitaxel
| Article | Year |
|---|---|
Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.
Topics: Animals; Combined Modality Therapy; Docetaxel; Heterocyclic Compounds; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Paclitaxel; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radioimmunotherapy; Taxoids; Transplantation, Heterologous; Yttrium | 2002 |
Mapping Drug-Induced Neuropathy through In-Situ Motor Protein Tracking and Machine Learning.
Topics: Animals; Antineoplastic Agents; Biological Transport; Fluorides; Ganglia, Spinal; Luminescent Agents; Metal Nanoparticles; Nerve Tissue Proteins; Neurons; Neurotoxicity Syndromes; Paclitaxel; Rats, Sprague-Dawley; Support Vector Machine; Thulium; Vincristine; Ytterbium; Yttrium | 2021 |